Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

NICE Blocks Yet More Anticancer Agents

August 2006 | Market Trend Analysis

The UK pharmaceutical cost-effectiveness regulator - NICE - has deemed that two breakthrough colon cancer drugs are too expensive despite being safe, highly effective, easier to tolerate than traditional chemotherapy, and available in every other EU

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Related Insight Articles
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
Pharmaceutical Distribution Revolution Accelerates

Companies / United Kingdom Two more multinational pharmaceutical companies have joined market leader Pfizer in rationalising their UK supply chain in an effort to prevent counterfeit products hitting the market. Furthermore, other...
December 2006
Health Research Body Formed

Companies / United Kingdom An organisation has been formed to oversee the operations of the UK's two largest public health research organisations in an effort to bolster the country's reputation as a leader in drug development....
December 2006
OTC Switches To Boost Medicines Access

Companies / United Kingdom Empowering patients and reducing the burden on healthcare providers, the UK has reclassified several medicines from either prescription-only medicine (POM) to pharmacy only or pharmacy only to general...
September 2006
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS